Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia
Overview
Oncology
Affiliations
As more women with transfusion-dependent thalassemia are seeking pregnancy, ensuring the best outcomes for both the mother and baby requires concerted, collaborative efforts between practitioners and the family. Proactive counseling, early fertility evaluation, recent developments in reproductive technology, and optimal management of iron overload, have resulted in more successful pregnancies and the birth of healthy newborns. With advances in technology for prenatal screening and increased awareness to perform screening for hemoglobinopathies, healthy pregnancy outcomes have become the expectation. Topics that require further study include management that allows fertility preservation, improved non-invasive prenatal diagnosis methods for affected fetuses, the use of chelation therapy during pregnancy, and indications for and duration of anticoagulation.
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice.
Pinto V, Cima R, Di Maggio R, Alga M, Gigante A, Longo F J Clin Med. 2025; 14(3).
PMID: 39941620 PMC: 11818879. DOI: 10.3390/jcm14030948.
Hematologic Complications of Pregnancy.
Patel P, Patel N, Hedges M, Benson A, Tomer A, Lo J Eur J Haematol. 2025; 114(4):596-614.
PMID: 39790057 PMC: 11882378. DOI: 10.1111/ejh.14372.
Ironing out β-thalassemia during pregnancy.
Simoneau J, Shah Y Blood. 2023; 142(2):128-129.
PMID: 37440270 PMC: 10352599. DOI: 10.1182/blood.2023020924.
Matthiesson H, Berdoukas V, Briganti E Matern Child Health J. 2023; 27(11):1961-1967.
PMID: 37273135 PMC: 10564654. DOI: 10.1007/s10995-023-03683-8.
Iron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms.
Sangkhae V, Fisher A, Ganz T, Nemeth E Annu Rev Nutr. 2023; 43:279-300.
PMID: 37253681 PMC: 10723031. DOI: 10.1146/annurev-nutr-061021-030404.